1. Home
  2. Live Updates
  3. ஜுவான் அன்றேல்

Page 6 - ஜுவான் அன்றேல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜுவான் அன்றேல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜுவான் அன்றேல் Today - Breaking & Trending Today

Moderna : and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine

The agreement will further enable global supply of mRNA-1273, Moderna’s COVID-19 vaccine with Samsung Biologics’ fill and finish manufacturing service
. | May 22, 2021 ....

Inch On Gwangyoksi , South Korea , Samsung Biologics , Juan Andres , Exchange Commission , Samsung Biologics Co Ltd , Manufacturing Services , Supply Agreement , Samsung Biologic , John Rim , Chief Technical Operations , Private Securities Litigation Reform Act , Annual Report , Nc Stock Exchange , Press Release , Anufacturing Mrna Us60770k1079 , தெற்கு கொரியா , சாம்சங் உயிரியல் , ஜுவான் அன்றேல் , பரிமாற்றம் தரகு , சாம்சங் உயிரியல் இணை லிமிடெட் , உற்பத்தி சேவைகள் , ஜான் விளிம்பு , தலைமை தொழில்நுட்ப செயல்பாடுகள் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் , ஆண்டு அறிக்கை ,

Moderna INC (MRNA) Q1 2021 Earnings Call Transcript


Operator
Good morning. My name is Dee Tamara, and I will be your operator today. Welcome to Moderna s first-quarter earnings call. [Operator instructions] Please be advised that the call is being recorded.
At this time, I d like to turn the call over to Lavina Talukdar, head, investor relations at Moderna. Please proceed.
Lavina Talukdar
Head of Investor Relations
Thank you, Dee Tamara. Good morning, everyone. Thank you for joining us on today s call to discuss Moderna s first-quarter 2021 financial results and business updates. You can access the press release issued this morning, as well as the slides that we ll be reviewing by going to the investors section of our website. ....

United States , Hong Kong , South Africa , Republic Of South Africa , Lavina Talukdar , Zuellig Pharma , Stephane Bancel , Dee Tamara , Corinne Le Goff , Stephen Hoge , David Meline , Asia Pacific , Juan Andres , World Health Organization , Tal Zaks , Private Securities Litigation Reform Act , United States Trade Ambassador , Southeast Asia , New England Journal , ஒன்றுபட்டது மாநிலங்களில் , ஹாங் காங் , லாவினா தாலுக்தார் , கோரிண்ணே லெ காஃப் , ஸ்டீபன் ஹொகே , ஆசியா பெஸிஃபிக் , ஜுவான் அன்றேல் ,

Moderna Announces Agreement with Sanofi for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.

Moderna Announces Agreement with Sanofi for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Lavina Talukdar , Juan Andres , Colleen Hussey , Human Services , Biden Administration , Exchange Commission , Corporate Communications , Department Of Health , Moderna Inc , Chief Technical Operations , Private Securities Litigation Reform Act , Annual Report , Vice President , Investor Relations , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , லாவினா தாலுக்தார் , ஜுவான் அன்றேல் , சக ஹஸ்ஸி , மனிதன் சேவைகள் , பரிமாற்றம் தரகு , பெருநிறுவன தகவல்தொடர்புகள் , துறை ஆஃப் ஆரோக்கியம் , மாடர்னா இன்க் ,

Moderna Announces Agreement with Sanofi for Fill/Finish Manufacturing of COVID-19 Vaccine


Credit: torstensimon/ Pixabay
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced that it has entered into an agreement with Sanofi (Nasdaq: SNY) for fill/finish sterile manufacturing services and supply packaging for up to 200 million doses of the Moderna COVID-19 Vaccine in the U.S. beginning in September 2021. Sanofi will leverage its established manufacturing infrastructure at its site in Ridgefield, NJ.
“We welcome the opportunity to work with Sanofi on fill/finish manufacturing for the Moderna COVID-19 Vaccine in the U.S. We would like to thank the Department of Health and Human Services and the Biden Administration for their assistance in securing this additional capacity,” said Juan Andres, Moderna’s Chief Technical Operations and Quality Officer. “This additional production will help us continue to scale up our manufacturing capacity in the United States.”FURTHER IN ....

United States , Juan Andres , Department Of Health , Human Services , Moderna Inc , Biden Administration , Chief Technical Operations , ஒன்றுபட்டது மாநிலங்களில் , ஜுவான் அன்றேல் , துறை ஆஃப் ஆரோக்கியம் , மனிதன் சேவைகள் , மாடர்னா இன்க் , தலைமை தொழில்நுட்ப செயல்பாடுகள் ,

Moderna Announces Agreement with Sanofi for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.


Search jobs
27-Apr-2021
Moderna Announces Agreement with Sanofi for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has entered into an agreement with Sanofi (Nasdaq: SNY) for fill/finish sterile manufacturing services and supply packaging for up to 200 million doses of the Moderna COVID-19 Vaccine in the U.S. beginning in September 2021. Sanofi will leverage its established manufacturing infrastructure at its site in Ridgefield, NJ.
“We welcome the opportunity to work with Sanofi on fill/finish manufacturing for the Moderna COVID-19 Vaccine in the U.S. We would like to thank the Department of Health and Human Services and the Biden Administration for their assistance in securing this additional capacity,” said Juan Andres, Moderna’s Chief ....

United States , Juan Andres , Department Of Health , Human Services , Moderna Inc , Biden Administration , Chief Technical Operations , ஒன்றுபட்டது மாநிலங்களில் , ஜுவான் அன்றேல் , துறை ஆஃப் ஆரோக்கியம் , மனிதன் சேவைகள் , மாடர்னா இன்க் , தலைமை தொழில்நுட்ப செயல்பாடுகள் ,